Fig. 3From: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancerAntiproliferative effect induced by transient transfection of LNA-i-miR-92a in endometrial cancer cell lines compared to scramble control (LNA-i-miR-NC): a HEC-1-B, b Ishikawa, c KLE; d antiproliferative effect induced by transient transfection of LNA-i-miR-92a in Ishikawa cell lines compared to untreated control (lipofectamine). Averaged values ± SD from three independent experiments performed in triplicates are presented. * p-value <0.05Back to article page